证券代码：600426 证券简称：华鲁恒升 公告编号：临 2025-027 山东华鲁恒升化工股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 4 月 29 日 (二)股东大会召开的地点：山东省德州市经济开发区东风东路 2555 号凤冠假日 酒店 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 680 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 869,166,797 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 40.9362 | | 份总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议采取现场投票与网络投票相结合的方式召开及表决。会议由公司董 事会召集，董事长常怀春先生主持。会议的召集、召开符合 ...

证券代码：600426 证券简称：华鲁恒升 编号：临 2025-028 山东华鲁恒升化工股份有限公司 关于回购股份注销减少注册资本通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、通知债权人的原因 山东华鲁恒升化工股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日、2025 年 4 月 29 日分别召开了第九届董事会 2025 年第 2 次临时会议、2024 年年度股东大会， 审议通过了《关于以集中竞价交易方式回购公司部分股份方案的议案》。同意公司自股 东大会审议通过之日起 12 个月内使用不低于人民币 20,000.00 万元（含），不高于人 民币 30,000.00 万元（含）的自有资金或自筹资金，通过集中竞价交易方式以不超过人 民币 32.38 元/股（含）的价格回购公司股份，本次回购股份将全部予以注销并减少公 司注册资本。 上述回购方案及股东大会决议内容详见公司分别于 2025 年 4 月 18 日、2025 年 4 月 30 日在上海证券交易所网站（www.sse.com.c ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于山东华鲁恒升化工股份有限公司 2024 年年度股东大会的 法律意见书 国枫律股字[2025]A0141 号 致：山东华鲁恒升化工股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2024 年年度股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东大会规则》（以下简 称"《股东大会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券 法律业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证 券法律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《山东华鲁恒升 化工股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与 召开程序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜，出 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company [2][4]. Core Views - The company reported a revenue of 7.772 billion yuan in Q1 2025, a year-on-year decrease of 2.59%, and a net profit attributable to shareholders of 707 million yuan, down 33.65% year-on-year. The decline in product prices has negatively impacted overall revenue growth [3]. - Despite the challenges, the company is actively advancing project construction, which is expected to provide new momentum for future development. Key projects include the melamine resin optimization project and the nylon 66 high-end new materials project, which are set to enhance production capacity [4]. - The company is projected to achieve net profits of 4.008 billion yuan, 4.587 billion yuan, and 5.351 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding EPS of 1.89 yuan, 2.16 yuan, and 2.52 yuan. The current stock price corresponds to P/E ratios of 11, 9, and 8 times for the same years [4]. Financial Performance Summary - In Q1 2025, the company's main products, including urea, isooctanol, nylon 6, and others, experienced a decline in prices, leading to a comprehensive gross margin decrease of 5.54 percentage points to 16.35% [3]. - The company’s revenue and profit forecasts for 2025-2027 indicate a gradual recovery, with revenue expected to grow from 36.405 billion yuan in 2025 to 45.073 billion yuan in 2027, reflecting a growth rate of 6.37% and 12.01%, respectively [5]. - The company’s net profit is projected to grow at rates of 2.71%, 14.44%, and 16.65% for the years 2025, 2026, and 2027, respectively [5].

Investment Rating - The investment rating for the company is "Buy" [3] Core Views - The company reported Q1 2025 revenue of 7.77 billion yuan, a year-over-year decrease of 3% and a quarter-over-quarter decrease of 14%. The net profit attributable to shareholders was 710 million yuan, down 34% year-over-year and 17% quarter-over-quarter [1][3] - The company is a leading player in the coal chemical industry in China, with a significant low-cost moat. The extension of the industrial chain and product expansion at the Jingzhou base are expected to drive steady growth in performance. Projected net profits for 2025-2027 are 4.036 billion, 4.666 billion, and 5.120 billion yuan, with year-over-year growth rates of 3.41%, 15.62%, and 9.73%, respectively [3][4] - The company is experiencing pressure on profitability due to product price declines, but cost reductions are expected to improve product price differentials in Q2, driven by industry recovery [8][9] Financial Summary - For 2025, the company is expected to achieve revenue of 37.041 billion yuan, with a year-over-year growth of 8.22%. The net profit is projected to be 4.036 billion yuan, reflecting a year-over-year growth of 3.41% [4][9] - The company's earnings per share (EPS) for 2025 is estimated at 1.90 yuan, with a price-to-earnings (P/E) ratio of 10.59 [4][9] - The company’s gross margin and net margin for Q1 2025 were 16.3% and 9.9%, respectively, indicating a decline in profitability due to lower product prices [8][9]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - In Q1 2025, the company achieved revenue of 7.772 billion yuan, a year-on-year decrease of 2.59%, and a net profit attributable to shareholders of 707 million yuan, down 33.65% year-on-year and 17.20% quarter-on-quarter. Despite most product price spreads being at historical lows, the company's net profit only declined by 1.47 billion yuan quarter-on-quarter, demonstrating strong performance resilience. The company announced a share buyback at a low market value, reflecting confidence in future development. The profit forecasts for 2025-2027 are maintained at 4.275 billion, 5.003 billion, and 5.760 billion yuan, with corresponding EPS of 2.01, 2.36, and 2.71 yuan per share, leading to PE ratios of 10.0, 8.5, and 7.4 times respectively. The company is expected to benefit from domestic policy support for demand recovery and falling coal prices, leading to a positive outlook for performance recovery [7][9]. Financial Summary - In Q1 2025, the average price of main products such as urea, acetic acid, and others showed a decline, with average prices of 1,727, 2,902, and 8,063 yuan per ton respectively, reflecting decreases of 3.40%, 2.07%, and 2.09% quarter-on-quarter. The average price spreads for these products were at historical low percentiles, indicating cost advantages and performance resilience for the company [8][9]. - The financial summary indicates that the company expects revenues of 32.107 billion yuan in 2025, with a year-on-year decrease of 6.2%. The net profit is projected to be 4.275 billion yuan, reflecting a year-on-year increase of 9.5%. The gross margin is expected to be 19.7%, and the net margin is projected at 13.6% [10][12].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - In Q1 2025, the company achieved revenue of 7.772 billion yuan, a year-on-year decrease of 2.59%, and a net profit attributable to shareholders of 707 million yuan, down 33.65% year-on-year and 17.20% quarter-on-quarter. Despite most product price spreads being at historical lows, the company's net profit only declined by 147 million yuan quarter-on-quarter, demonstrating strong performance resilience [6][8] - The company announced a share buyback plan, indicating confidence in future development, with a buyback amount not less than 200 million yuan and not exceeding 300 million yuan [8] - The company maintains its profit forecast for 2025-2027, expecting net profits of 4.275 billion, 5.003 billion, and 5.760 billion yuan, with corresponding EPS of 2.01, 2.36, and 2.71 yuan per share, leading to PE ratios of 10.0, 8.5, and 7.4 times respectively [6][9] Financial Summary - In Q1 2025, the average price of main products such as urea, acetic acid, and others showed a decline, with average prices of 1,727, 2,902, and 8,063 yuan per ton respectively, reflecting a quarter-on-quarter decrease [7] - The company’s financial metrics for 2023A to 2027E include projected revenues of 27.26 billion, 34.23 billion, 32.11 billion, 32.36 billion, and 32.62 billion yuan respectively, with net profits expected to grow from 3.576 billion to 5.760 billion yuan over the same period [9][11] - The gross margin is projected to improve from 20.9% in 2023A to 23.8% in 2027E, while the net margin is expected to rise from 13.3% to 18.2% [11]

Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Views - The company reported a revenue of 7.77 billion yuan in Q1 2025, a year-on-year decrease of 2.6% and a quarter-on-quarter decrease of 14.1%. The net profit attributable to shareholders was 710 million yuan, down 33.7% year-on-year and 17.2% quarter-on-quarter. The net profit after deducting non-recurring gains and losses was 700 million yuan, reflecting a year-on-year decline of 34.2% and a quarter-on-quarter decline of 13.3% [2][6]. Summary by Sections Financial Performance - In Q1 2025, the company experienced a decline in revenue and profit, with a revenue of 77.7 billion yuan and a net profit of 7.1 billion yuan. The gross margin was 16.3%, showing a quarter-on-quarter increase of 1.2 percentage points, while the net margin remained stable at 9.9% [2][12]. Market Conditions - The market prices for key products in Q1 2025 showed varied changes, with urea decreasing by 2.5% and DMF by 1.7%. The company’s sales volume for organic amine series products, chemical fertilizers, and acetic acid saw significant quarter-on-quarter declines of 11.1%, 3.9%, and 20.7%, respectively [12]. Future Outlook - The company is positioned at the bottom of the cycle, with expectations for gradual improvement in operations due to ongoing demand recovery and the release of new production capacity from the Jingzhou base. The company anticipates net profits of 3.72 billion yuan, 4.16 billion yuan, and 4.70 billion yuan for 2025, 2026, and 2027, respectively [12][12].

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company's Q1 2025 performance met expectations, with total revenue of 7.77 billion yuan, a year-on-year decrease of 2.6%, and a net profit attributable to shareholders of 707 million yuan, down 33.7% year-on-year [6] - The report highlights that product price differentials are at a bottom level, with seasonal factors impacting product shipments [6] - The company is expected to see gradual recovery in demand and cost pressures easing, with new projects contributing to growth [6] Financial Data and Profit Forecast - Total revenue projections for 2025 are 35.92 billion yuan, with a year-on-year growth rate of 5.0% [2] - Net profit attributable to shareholders is forecasted at 3.97 billion yuan for 2025, reflecting a slight increase of 1.7% year-on-year [2] - Earnings per share are expected to be 1.87 yuan in 2025, with a projected PE ratio of 11 [2] Market Data - As of April 25, 2025, the closing price of the stock is 20.97 yuan, with a market capitalization of 44.44 billion yuan [3] - The stock has a price-to-book ratio of 1.4 and a dividend yield of 4.29% [3] Product and Cost Analysis - The report notes that the average price differentials for key products are at historical lows, with significant declines in raw material prices, easing cost pressures [6] - The company is expected to benefit from new high-end chemical projects coming online, enhancing its competitive edge [6]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company's Q1 performance was under pressure, with revenue of 7.772 billion yuan, a year-on-year decrease of 2.59% and a quarter-on-quarter decrease of 14.09%. The net profit attributable to shareholders was 707 million yuan, down 33.65% year-on-year and 17.20% quarter-on-quarter. The decline in sales of organic amines and acetic acid significantly impacted revenue and profit [8][12] - Despite the challenges, the company is expected to benefit from lower coal prices, which may reduce costs and improve performance in the future [8][12] - The company is actively advancing its construction projects, which are expected to provide new growth momentum [11][12] Summary by Sections Financial Performance - In Q1 2025, the company achieved revenue of 77.72 billion yuan, a decrease of 2.06 billion yuan year-on-year and 12.74 billion yuan quarter-on-quarter. Gross profit was 12.71 billion yuan, down 4.75 billion yuan year-on-year and 0.95 billion yuan quarter-on-quarter. The net profit attributable to shareholders was 7.07 billion yuan, down 3.58 billion yuan year-on-year and 1.47 billion yuan quarter-on-quarter [8][12] - The company's sales volume for fertilizers reached 1.4533 million tons, an increase of 36.74% year-on-year but a decrease of 3.91% quarter-on-quarter. Organic amines and acetic acid saw significant declines in sales volume [8][12] Market Conditions - The average price of urea in Q1 2025 was 1,734 yuan/ton, down 22% year-on-year and 3% quarter-on-quarter. The average price of acetic acid was 2,762 yuan/ton, down 8% year-on-year but up 4% quarter-on-quarter [8][12] - The company’s main product prices are currently experiencing low volatility, but the significant drop in coal prices is expected to improve the company's performance in the coming quarters [10][12] Future Outlook - The company forecasts revenues of 37.5 billion yuan, 41.2 billion yuan, and 45.6 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 4.46 billion yuan, 5.01 billion yuan, and 5.72 billion yuan for the same years. The corresponding P/E ratios are projected to be 10, 9, and 8 times [12][14] - The ongoing construction projects are expected to enhance the company's growth potential, supporting the positive outlook [11][12]